[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Anti-tumor Drug Market - Global Outlook and Forecast 2021-2027

January 2021 | 105 pages | ID: AE6DFF205E66EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Anti-tumor Drug in Global, including the following market information:
Global Anti-tumor Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Anti-tumor Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-tumor Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-tumor Drug Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Anti-tumor Drug Market Segment Percentages, By Type, 2020 (%)
  • Cytotoxic Drugs
  • Non-cytotoxic Drugs
China Anti-tumor Drug Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Anti-tumor Drug Market Segment Percentages, By Application, 2020 (%)
  • Alkylating Agents
  • Anti-Metabolism Drugs
  • Platinum Antineoplastic Agents
  • Anthracycline Antitumor Drugs
  • Microtubule Stabilizer
  • Endocrine Therapy Drugs
  • Immunotherapy Drugs
  • Gene Therapy Drugs
  • Targeted Antineoplastic Drugs
Global Anti-tumor Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Anti-tumor Drug Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Anti-tumor Drug Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Anti-tumor Drug Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
  • Roche
  • Novartis
  • Celgene
  • Bristol-Myers Squibb
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Astellas
  • Merck & Co
  • Sanofi
  • Bayer
  • Biogen Idec
  • Eisai
  • Teva
  • Otsuka
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-tumor Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-tumor Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-TUMOR DRUG OVERALL MARKET SIZE

2.1 Global Anti-tumor Drug Market Size: 2021 VS 2027
2.2 Global Anti-tumor Drug Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-tumor Drug Players in Global Market
3.2 Top Global Anti-tumor Drug Companies Ranked by Revenue
3.3 Global Anti-tumor Drug Revenue by Companies
3.4 Top 3 and Top 5 Anti-tumor Drug Companies in Global Market, by Revenue in 2020
3.5 Global Companies Anti-tumor Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-tumor Drug Players in Global Market
  3.6.1 List of Global Tier 1 Anti-tumor Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-tumor Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-tumor Drug Market Size Markets, 2021 & 2027
  4.1.2 Cytotoxic Drugs
  4.1.3 Non-cytotoxic Drugs
4.2 By Type - Global Anti-tumor Drug Revenue & Forecasts
  4.2.1 By Type - Global Anti-tumor Drug Revenue, 2016-2021
  4.2.2 By Type - Global Anti-tumor Drug Revenue, 2022-2027
  4.2.3 By Type - Global Anti-tumor Drug Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-tumor Drug Market Size, 2021 & 2027
  5.1.2 Alkylating Agents
  5.1.3 Anti-Metabolism Drugs
  5.1.4 Platinum Antineoplastic Agents
  5.1.5 Anthracycline Antitumor Drugs
  5.1.6 Microtubule Stabilizer
  5.1.7 Endocrine Therapy Drugs
  5.1.8 Immunotherapy Drugs
  5.1.9 Gene Therapy Drugs
  5.1.10 Targeted Antineoplastic Drugs
5.2 By Application - Global Anti-tumor Drug Revenue & Forecasts
  5.2.1 By Application - Global Anti-tumor Drug Revenue, 2016-2021
  5.2.2 By Application - Global Anti-tumor Drug Revenue, 2022-2027
  5.2.3 By Application - Global Anti-tumor Drug Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Anti-tumor Drug Market Size, 2021 & 2027
6.2 By Region - Global Anti-tumor Drug Revenue & Forecasts
  6.2.1 By Region - Global Anti-tumor Drug Revenue, 2016-2021
  6.2.2 By Region - Global Anti-tumor Drug Revenue, 2022-2027
  6.2.3 By Region - Global Anti-tumor Drug Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Anti-tumor Drug Revenue, 2016-2027
  6.3.2 US Anti-tumor Drug Market Size, 2016-2027
  6.3.3 Canada Anti-tumor Drug Market Size, 2016-2027
  6.3.4 Mexico Anti-tumor Drug Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Anti-tumor Drug Revenue, 2016-2027
  6.4.2 Germany Anti-tumor Drug Market Size, 2016-2027
  6.4.3 France Anti-tumor Drug Market Size, 2016-2027
  6.4.4 U.K. Anti-tumor Drug Market Size, 2016-2027
  6.4.5 Italy Anti-tumor Drug Market Size, 2016-2027
  6.4.6 Russia Anti-tumor Drug Market Size, 2016-2027
  6.4.7 Nordic Countries Anti-tumor Drug Market Size, 2016-2027
  6.4.8 Benelux Anti-tumor Drug Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Anti-tumor Drug Revenue, 2016-2027
  6.5.2 China Anti-tumor Drug Market Size, 2016-2027
  6.5.3 Japan Anti-tumor Drug Market Size, 2016-2027
  6.5.4 South Korea Anti-tumor Drug Market Size, 2016-2027
  6.5.5 Southeast Asia Anti-tumor Drug Market Size, 2016-2027
  6.5.6 India Anti-tumor Drug Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Anti-tumor Drug Revenue, 2016-2027
  6.6.2 Brazil Anti-tumor Drug Market Size, 2016-2027
  6.6.3 Argentina Anti-tumor Drug Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-tumor Drug Revenue, 2016-2027
  6.7.2 Turkey Anti-tumor Drug Market Size, 2016-2027
  6.7.3 Israel Anti-tumor Drug Market Size, 2016-2027
  6.7.4 Saudi Arabia Anti-tumor Drug Market Size, 2016-2027
  6.7.5 UAE Anti-tumor Drug Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Anti-tumor Drug Major Product Offerings
  7.1.4 Roche Anti-tumor Drug Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Anti-tumor Drug Major Product Offerings
  7.2.4 Novartis Anti-tumor Drug Revenue in Global (2016-2021)
  7.2.5 Novartis Key News
7.3 Celgene
  7.3.1 Celgene Corporate Summary
  7.3.2 Celgene Business Overview
  7.3.3 Celgene Anti-tumor Drug Major Product Offerings
  7.3.4 Celgene Anti-tumor Drug Revenue in Global (2016-2021)
  7.3.5 Celgene Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Anti-tumor Drug Major Product Offerings
  7.4.4 Bristol-Myers Squibb Anti-tumor Drug Revenue in Global (2016-2021)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Amgen
  7.5.1 Amgen Corporate Summary
  7.5.2 Amgen Business Overview
  7.5.3 Amgen Anti-tumor Drug Major Product Offerings
  7.5.4 Amgen Anti-tumor Drug Revenue in Global (2016-2021)
  7.5.5 Amgen Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Anti-tumor Drug Major Product Offerings
  7.6.4 Johnson & Johnson Anti-tumor Drug Revenue in Global (2016-2021)
  7.6.5 Johnson & Johnson Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Anti-tumor Drug Major Product Offerings
  7.4.4 Pfizer Anti-tumor Drug Revenue in Global (2016-2021)
  7.7.5 Pfizer Key News
7.8 Takeda
  7.8.1 Takeda Corporate Summary
  7.8.2 Takeda Business Overview
  7.8.3 Takeda Anti-tumor Drug Major Product Offerings
  7.8.4 Takeda Anti-tumor Drug Revenue in Global (2016-2021)
  7.8.5 Takeda Key News
7.9 Eli Lilly
  7.9.1 Eli Lilly Corporate Summary
  7.9.2 Eli Lilly Business Overview
  7.9.3 Eli Lilly Anti-tumor Drug Major Product Offerings
  7.9.4 Eli Lilly Anti-tumor Drug Revenue in Global (2016-2021)
  7.9.5 Eli Lilly Key News
7.10 AstraZeneca
  7.10.1 AstraZeneca Corporate Summary
  7.10.2 AstraZeneca Business Overview
  7.10.3 AstraZeneca Anti-tumor Drug Major Product Offerings
  7.10.4 AstraZeneca Anti-tumor Drug Revenue in Global (2016-2021)
  7.10.5 AstraZeneca Key News
7.11 Astellas
  7.11.1 Astellas Corporate Summary
  7.11.2 Astellas Business Overview
  7.11.3 Astellas Anti-tumor Drug Major Product Offerings
  7.11.4 Astellas Anti-tumor Drug Revenue in Global (2016-2021)
  7.11.5 Astellas Key News
7.12 Merck & Co
  7.12.1 Merck & Co Corporate Summary
  7.12.2 Merck & Co Business Overview
  7.12.3 Merck & Co Anti-tumor Drug Major Product Offerings
  7.12.4 Merck & Co Anti-tumor Drug Revenue in Global (2016-2021)
  7.12.5 Merck & Co Key News
7.13 Sanofi
  7.13.1 Sanofi Corporate Summary
  7.13.2 Sanofi Business Overview
  7.13.3 Sanofi Anti-tumor Drug Major Product Offerings
  7.13.4 Sanofi Anti-tumor Drug Revenue in Global (2016-2021)
  7.13.5 Sanofi Key News
7.14 Bayer
  7.14.1 Bayer Corporate Summary
  7.14.2 Bayer Business Overview
  7.14.3 Bayer Anti-tumor Drug Major Product Offerings
  7.14.4 Bayer Anti-tumor Drug Revenue in Global (2016-2021)
  7.14.5 Bayer Key News
7.15 Biogen Idec
  7.15.1 Biogen Idec Corporate Summary
  7.15.2 Biogen Idec Business Overview
  7.15.3 Biogen Idec Anti-tumor Drug Major Product Offerings
  7.15.4 Biogen Idec Anti-tumor Drug Revenue in Global (2016-2021)
  7.15.5 Biogen Idec Key News
7.16 Eisai
  7.16.1 Eisai Corporate Summary
  7.16.2 Eisai Business Overview
  7.16.3 Eisai Anti-tumor Drug Major Product Offerings
  7.16.4 Eisai Anti-tumor Drug Revenue in Global (2016-2021)
  7.16.5 Eisai Key News
7.17 Teva
  7.17.1 Teva Corporate Summary
  7.17.2 Teva Business Overview
  7.17.3 Teva Anti-tumor Drug Major Product Offerings
  7.17.4 Teva Anti-tumor Drug Revenue in Global (2016-2021)
  7.17.5 Teva Key News
7.18 Otsuka
  7.18.1 Otsuka Corporate Summary
  7.18.2 Otsuka Business Overview
  7.18.3 Otsuka Anti-tumor Drug Major Product Offerings
  7.18.4 Otsuka Anti-tumor Drug Revenue in Global (2016-2021)
  7.18.5 Otsuka Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Anti-tumor Drug Market Opportunities & Trends in Global Market
Table 2. Anti-tumor Drug Market Drivers in Global Market
Table 3. Anti-tumor Drug Market Restraints in Global Market
Table 4. Key Players of Anti-tumor Drug in Global Market
Table 5. Top Anti-tumor Drug Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Anti-tumor Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Anti-tumor Drug Revenue Share by Companies, 2016-2021
Table 8. Global Companies Anti-tumor Drug Product Type
Table 9. List of Global Tier 1 Anti-tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Anti-tumor Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Anti-tumor Drug Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Anti-tumor Drug Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Anti-tumor Drug Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Anti-tumor Drug Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Anti-tumor Drug Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Anti-tumor Drug Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Anti-tumor Drug Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Anti-tumor Drug Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Anti-tumor Drug Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Anti-tumor Drug Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Anti-tumor Drug Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Anti-tumor Drug Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Anti-tumor Drug Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Anti-tumor Drug Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Anti-tumor Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Anti-tumor Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Anti-tumor Drug Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Anti-tumor Drug Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Anti-tumor Drug Product Offerings
Table 32. Roche Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Anti-tumor Drug Product Offerings
Table 35. Novartis Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 36. Celgene Corporate Summary
Table 37. Celgene Anti-tumor Drug Product Offerings
Table 38. Celgene Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Anti-tumor Drug Product Offerings
Table 41. Bristol-Myers Squibb Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 42. Amgen Corporate Summary
Table 43. Amgen Anti-tumor Drug Product Offerings
Table 44. Amgen Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Anti-tumor Drug Product Offerings
Table 47. Johnson & Johnson Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Anti-tumor Drug Product Offerings
Table 50. Pfizer Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 51. Takeda Corporate Summary
Table 52. Takeda Anti-tumor Drug Product Offerings
Table 53. Takeda Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 54. Eli Lilly Corporate Summary
Table 55. Eli Lilly Anti-tumor Drug Product Offerings
Table 56. Eli Lilly Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 57. AstraZeneca Corporate Summary
Table 58. AstraZeneca Anti-tumor Drug Product Offerings
Table 59. AstraZeneca Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 60. Astellas Corporate Summary
Table 61. Astellas Anti-tumor Drug Product Offerings
Table 62. Astellas Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 63. Merck & Co Corporate Summary
Table 64. Merck & Co Anti-tumor Drug Product Offerings
Table 65. Merck & Co Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 66. Sanofi Corporate Summary
Table 67. Sanofi Anti-tumor Drug Product Offerings
Table 68. Sanofi Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 69. Bayer Corporate Summary
Table 70. Bayer Anti-tumor Drug Product Offerings
Table 71. Bayer Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 72. Biogen Idec Corporate Summary
Table 73. Biogen Idec Anti-tumor Drug Product Offerings
Table 74. Biogen Idec Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 75. Eisai Corporate Summary
Table 76. Eisai Anti-tumor Drug Product Offerings
Table 77. Eisai Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 78. Teva Corporate Summary
Table 79. Teva Anti-tumor Drug Product Offerings
Table 80. Teva Anti-tumor Drug Revenue (US$, Mn), (2016-2021)
Table 81. Otsuka Corporate Summary
Table 82. Otsuka Anti-tumor Drug Product Offerings
Table 83. Otsuka Anti-tumor Drug Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Anti-tumor Drug Segment by Type
Figure 2. Anti-tumor Drug Segment by Application
Figure 3. Global Anti-tumor Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-tumor Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anti-tumor Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-tumor Drug Revenue in 2020
Figure 8. By Type - Global Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 9. By Application - Global Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 10. By Region - Global Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 11. By Country - North America Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 12. US Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 16. Germany Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 17. France Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 24. China Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 28. India Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 30. Brazil Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Anti-tumor Drug Revenue Market Share, 2016-2027
Figure 33. Turkey Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Anti-tumor Drug Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Celgene Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bristol-Myers Squibb Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Amgen Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Johnson & Johnson Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Pfizer Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Takeda Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Eli Lilly Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. AstraZeneca Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Astellas Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Merck & Co Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Sanofi Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Bayer Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Biogen Idec Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Eisai Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Teva Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications